WRAPUP 1-AstraZeneca to issue trial update after U.S. criticism over data
LONDON, March 23 (Reuters) - AstraZeneca will release the most up-to-date results from its latest COVID-19 vaccine trial within 48 hours after U.S. health officials publicly criticised the drugmaker for using outdated information in a press relea...
Read more